New York, USA – January 5, 2023 – CD BioSciences, the platform committed to providing a full range of tumor research services to hospitals, research institutions and scientific researchers. CD BioSciences has organized a large number of experienced technicians and built a series of integrated end-to-end solutions to support research on the tumor microenvironment. Recently, CD BioSciences announced the release of its full range of tumor microenvironment related research services and solutions to promote the process of new drug research.
TME center technology platform consists of a series of independent business platforms, including microfluidic technology platform, sequencing technology platform, mass spectrometry technology platform, imaging technology platform, immune cell technology platform, stem cell technology platform, animal model technology platform, animal experiment platform, etc. TME center technology platform can freely combine platform technologies according to different research purposes, and support various single or integrated projects.
CD BioSciences focuses on the research of tumor microenvironments. There are many seasoned experts in the field who can collaborate with each other for more in-depth brainstorming. Meanwhile, a batch of advanced experimental equipment has been introduced to provide customers with professional, efficient and high-quality services.
CD BioSciences has established a mature tumor microenvironment center technology platform with an experienced team of tumor model customization experts and mature technology, aiming to provide customers with efficient and verified tumor models for tumor and microenvironment research and anti-tumor drug discovery. Available services include combined services for existing models, custom models and new model development.
CD BioSciences has established a complete tumor microenvironment center technology platform with an experienced expert team and mature technology, aiming to provide efficient and validated tumor models for tumor and microenvironment research and anticancer drug discovery. Among them, the single-cell multi-omics platform combines space-omics technology to study the tumor microenvironment from a multi-level, multi-perspective, and multi-omics perspective.
“We provide a full range of consulting, design, implementation, management, reporting and analysis services related to tumor microenvironment research to scientists and researchers around the world,” said Marcia Brady, the marketing director of CD BioSciences. She also added, “We are committed to high-quality tumor microenvironment research, basic experiments and scientific research solutions, providing customers with one-stop scientific research services.”
About CD BioSciences
CD BioSciences provides global scientists and researchers with a full range of consulting, design, implementation, management, reporting and analysis services related to the study of the tumor microenvironment. CD BioSciences can help customers solve project problems or open up new research directions in all aspects to speed up research. In addition, we can also customize solutions for you according to your scientific research needs.
Media Contact
Company Name: CD BioSciences
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-372-1052
Country: United States
Website: https://www.tmecenter.com